Tonix Pharmaceuticals Holding Corp. Annual Costs and Expenses in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Costs and Expenses history and growth rate from 2015 to 2023.
  • Tonix Pharmaceuticals Holding Corp. Costs and Expenses for the quarter ending September 30, 2024 was $18.4M, a 42.8% decline year-over-year.
  • Tonix Pharmaceuticals Holding Corp. Costs and Expenses for the twelve months ending September 30, 2024 was $153M, a 19.6% increase year-over-year.
  • Tonix Pharmaceuticals Holding Corp. annual Costs and Expenses for 2023 was $126M, a 12.5% increase from 2022.
  • Tonix Pharmaceuticals Holding Corp. annual Costs and Expenses for 2022 was $112M, a 21.4% increase from 2021.
  • Tonix Pharmaceuticals Holding Corp. annual Costs and Expenses for 2021 was $92.3M, a 82.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $126M +$14.1M +12.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $112M +$19.8M +21.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $92.3M +$41.8M +82.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 $50.5M +$21.7M +75.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $28.8M +$2.51M +9.52% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $26.3M +$5.03M +23.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 $21.3M -$17.7M -45.4% Jan 1, 2017 Dec 31, 2017 10-K/A 2019-03-18
2016 $39M -$9.19M -19.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 $48.2M Jan 1, 2015 Dec 31, 2015 10-K 2017-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.